Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Avidly Plc’s Board of Directors resolved on a rights issue and publishes the terms and conditions and basic information document of the rights issue

Avidly Plc, Company Annoucement, 14 May 2020 at 10.00 am EEST AVIDLY PLC’S BOARD OF DIRECTORS RESOLVED ON A RIGHTS ISSUE AND PUBLISHES THE TERMS AND CONDITIONS AND BASIC INFORMATION DOCUMENT OF THE RIGHTS ISSUE NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER COUNTRY WHERE THE DISTRIBUTION OR PUBLICATION WOULD BE ILLEGAL. The Board of Directors of Avidly Plc (“Company” or “Avidly”) has on 14 May 2020, pursuant to an authorization granted by the Company’s annual

Interim Report Q1 2020-01-01 - 2020-03-31

The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the first quarter 2020.Summary of the Interim Report Cereno Scientific Group  (2020-01-01 – 2020-03-31) · Net Sales were 0 SEK. · Loss after financial items was SEK -3,752,667. · Loss per share was SEK -0.09 before dilution and SEK -0.09after dilution*. · The equity/assets ratio was 93.8 %. Parent company Three months (1 January 2020 – 31 March 2020) · Net sales were SEK 0 (0). · Loss after financial items was SEK -3,753,523 (-5,333,633). · Loss per

Arctic Paper S.A., Q1 2020: Strong Q1 prepare the Group for tougher times

• Q1 consolidated sales revenue was PLN 813,9mn (EUR[1] 188,2mn).• EBITDA Q1 was PLN 111,8mn (EUR[1] 25,9mn).• EBIT Q1 was PLN 79,7mn (EUR[1] 18,4mn) and net profit PLN 62,3mn (EUR[1] 14,4mn).• A combination of strong paper and stable pulp boosted Q1 results.• At the end of the period there is a decline in demand due to Covid-19.• Measures taken to mitigate negative effects: short-term allowance for Grycksbo and Munkedal.• The board has decided not to recommend dividend for 2019. “After a solid fourth quarter 2019 and a robust beginning of this year, the Group stands strong and

TORM plc First Quarter Report 2020

“During the first quarter of 2020, TORM obtained a profit before tax of USD 57m, which represents the strongest start to a year in more than a decade. The strong start has continued and has further enhanced so far in the second quarter where TORM has secured record bookings, with 69% of the earning days covered at USD/day 29,188, driven by the current logistical inefficiencies and increased interest in floating storage due to contango in the oil price,” says Executive Director Jacob Meldgaard. · In the first quarter of 2020, TORM achieved TCE rates of USD/day 23,643 (2019, same period:

Redsense Medical AB sees continued order intake in Europe despite the corona crisis

The COVID-19 pandemic has prompted governments all over Europe to implement far-reaching restrictions and lockdowns in an effort to curb the outbreak and mitigate its toll on society. As the various sanctions now cautiously and gradually are being relaxed and lifted across different countries and the wheels of the economy slowly are put in motion, Redsense Medical notes that the strict lockdowns as yet have not had any material impact on the Company’s order intake in Europe.  Throughout the crisis, the Company has continued to receive orders on the European markets of operation like

2020 Bulkers Ltd. (2020) – Commercial update April, 2020

Hamilton, Bermuda, May 14, 2020 Commercial update: In April 2020, the Company achieved average time charter equivalent earnings of approximately US$18,000 per day, gross. The Company’s two vessels trading on index-linked time charter earned approximately US$10,700 per day, gross, including average daily scrubber benefits of approximately US$900 per day. The Company’s four vessels trading on fixed time charter earned approximately US$21,600 per day, gross. The Baltic 5TC Capesize Index averaged US$7,757 during April 2020. For further queries, please contact: Magnus Halvorsen,

Cereno Scientific Publishes Annual Report for 2019

Today, the Board of Directors of Cereno Scientific AB publishes the Annual Report for the fiscal year 2019. The Annual Report is available on the Company's (www.cerenoscientific.com) and Spotlight Stock Market's (www.spotlightstockmarket.com) websites.For further information, please contact:Daniel Brodén – CFOTel: +46 768 66 77 87E-mail: info@cerenoscientific.comwww.cerenoscientific.se About Cereno Scientific ABCereno Scientific is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase

Interim Report January–March 2020

ChromoGenics completed a preferential share issue for SEK 76.2 million to accelerate growthQ1 2020 · Net sales for the period amounted to SEK 5.2 (10.7) million, and earnings amounted to SEK -19.5 (-16.3) million, which corresponds to earnings per share of SEK -0.04 (-0.25). · Due to the coronavirus pandemic, orders from the company’s customers have been delayed. Order intake and invoicing in 2020 have been pushed to later in the year, and the net sales for the year are therefore expected to be lower than the net sales in 2019. Given this, the Board of Directors has decided to roll

Bactiguard donates money to research on COVID-19

To contribute to the research on COVID-19, Bactiguard donates SEK 120,000 to Karolinska Institutet (KI) at Danderyd Hospital."We have collaborated with Karolinska Institutet at Danderyd Hospital (KI DS) since 2010, where we share lab resources to be able to test how Bactiguard's coating technology interacts with blood. In addition, Bactiguard has actively engaged in the fight against COVID-19 and being able to contribute further was natural to us,” says Stefan Grass, Chief Medical Officer. The donation will be used to further equip a lab at Karolinska Institutet at Danderyd Hospital, so

Notice of Annual General Meeting of Vitrolife AB (publ)

The Annual General Meeting (“AGM”) of Vitrolife AB (publ) will take place on Monday June 15, 2020, at 4.30 p.m. at Hotell Gothia Towers, Mässans gata 24, in Gothenburg, Sweden. Notice of attendance at the AGM shall be given no later than Tuesday, June 9, 2020. Due to the current uncertainty following the covid-19 pandemic, the Board of Directors has resolved to withdraw its current dividend proposal of SEK 1.05 per share. The Board proposes that the AGM resolves that no dividend will be paid.Shareholders wishing to participate at the AGM shall notify the company by mail to Vitrolife AB (

Continued strong development in NOTE during Q2 and the plant in Windsor reopened

At the end of March and in line with the British authorities' decision to limit all unnecessary travel and industrial operations, the Windsor plant suspended production. The plant in Windsor accounts for about 10% of NOTE's total sales. The closure is subject to the UK authorities' support measures, which include, among other things, full compensation for the salary cost of laid-off staff. Based on instructions from the local authorities, NOTE has taken the necessary steps to reopen the plant for production. Capacity utilisation at the Windsor plant is expected to increase gradually during

Mentice publishes the company’s interim report for the period January–March 2020

Encouraging signs for the medium to long-term outlook, while the uncertainty in 2020 remains  First quarter 2020 · Net sales amounted to 33.8 (27.5) MSEK. · Operating result for the period before depreciations (EBITDA) totalled -0.5 (-7.9) MSEK. · Net result for the period amounted to -5.0 (-8.5) MSEK. · Earnings per share (EPS) was -0.21 (-0.76) SEK. · Order intake amounted to 32.5 (25.1) MSEK. · Cash flow from operating activities totalled 1.5 (-3.7) MSEK. “In the first quarter, we managed to regain some of the projects that did not materialise in 2019. This

Endomines AB Q1 2020 Business Review - Ramp-up towards commercial production at Friday continues

Endomines AB, Stock Exchange Release 14 May 2020 at 08:30 CET Jan-Mar 2020 (Jan-Mar 2019) Operational highlights · Letter of intent signed with Transatlantic Mining to purchase US Grant Mine and mill and Kearsarge Gold Project · Concentrate sales agreement signed with H&H Metals for the sale of gold concentrates produced from the Company’s Friday Mine · Gold concentrate production continued to ramp-up successfully, however no gold concentrate was sold in Q1 2020 from Friday · No injuries reported in Q1 2020, LTIFR 0 (12) Financial highlights · Total revenue was 3.

Stora Enso appoints Katariina Kravi as Head of Human Resources

STORA ENSO OYJ STOCK EXCHANGE RELEASE 14 May 2020 at 9.30 EESTStora Enso has appointed Katariina Kravi as EVP, Head of Human Resources and a member of the Group Leadership Team. She will start on 1 September 2020 and be based in Helsinki. Katariina Kravi is a Finnish citizen and joins most recently from a position as Chief People and Culture Officer at Tieto Oyj, a leading Nordic software and services company. Previously she has held several HR management positions at Nokia. She has a master’s degree in law.“Katariina Kravi’s experience in leading change, digital transformation and

Evolution adds three exciting titles to its growing First Person range

Evolution Gaming, leading provider of Live Casino solutions, has today announced the addition of three new titles — First Person Baccarat, First Person Dragon Tiger and First Person Football Studio — to its growing range of RNG (random number generator) games with integrated ‘GO LIVE’ functionality. The new additions are based on three of Evolution’s live dealer tables: the casino classics Baccarat and Dragon Tiger, and the football-themed Top Card variant, Football Studio.The three latest titles join a richly varied and growing Evolution First Person range that already includes RNG

Raute delivers modern veneer drying and lay-up technology to China

RAUTE CORPORATION PRESS RELEASE 14 MAY 2020 at 9:30 a.m. RAUTE DELIVERS MODERN VENEER DRYING AND LAY-UP TECHNOLOGY TO CHINA Raute has signed a contract with Guoxu-Springwood Wood Panel Company in Guangxi province in South China for delivering a modern veneer dryer and automated lay-up lines, including Raute Mecano analyzers for quality control and modern moisture control. Despite the contract’s moderate size it has a high reference value for Raute as it is the first order of such modern technology to China. The ordered machinery and equipment will be delivered by the end of 2020.

Targovax announces that the ONCOS-102 and durvalumab abstract is selected for a Poster Discussion Session at ASCO

· The abstract describes the dose-escalation part of the ONCOS-102 and durvalumab combination trial in peritoneal malignancies · The abstract has been selected for the Poster Discussion Session Developmental Therapeutics—Immunotherapy to be presented 29 May at the ASCO 2020 virtual meeting Oslo, Norway, 14 May 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces that an abstract relating to the dose escalation part of the ONCOS-102 and durvalumab trial in primary ovarian and

Notice of Annual General Meeting of Eniro AB

Welcome to the annual general meeting of Eniro AB (publ), reg. no 556588–0936, (”Eniro” or the “Company”) Tuesday 16 June 2020 at 16.00 in Helio’s premises, Kista Timebuilding, Kistagången 12, in Kista. Registration to the annual general meeting starts at 15.00. PRECAUTIONARY MEASURES CONCERNING RISK OF SPREAD OF THE CORONA VIRUS At the time of issuing this notice, the Swedish Public Health Authority (Sw. Folkhälsomyndigheten) estimates that the risk of spreading the corona virus (COVID-19) is very high. To reduce the overall risk of infection, the current recommendation from the

Invitation to presentation of Sectra’s year-end report on June 3 – including in-depth presentation of subscription model

Linköping, Sweden – May 14, 2020 – The international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will publish its year-end report for the 2019/2020 fiscal year on June 3, 2020. Sectra invites analysts, investors, and the media to attend a teleconference/audiocast in conjunction with the publication of the report.Publication of year-end report: 8:15 a.m. CEST June 3, 2020Presentation: 10:00 a.m. CEST June 3, 2020 The presentation will be held remotely on account of the continued spread of COVID-19. To participate, follow online at

Positive cash flow and strong financial position

Summary of January – March 2020 · Net sales for projects run entirely by SSM increased to 48.9 MSEK (15.4), of which 35.8 MSEK was revenue recognized from the Täby Turf rental project. · Net operating profit improved and totaled 0.8 MSEK (-12.4). The West Side Solna and Metronomen cooperative apartment projects had a 6.6 MSEK and 6.4 MSEK impact on results respectively. · Cash flow from operating activities amounted to 13.7 MSEK ( 32.0), of which the divestment of Bromma Square in Q4 2019 contributed 42.9 MSEK during Q1 2020. · Agreement to sell half of the shares in the

SSM adapts organization

In 2019, SSM Holding AB (publ), Sweden’s leading developer of smart, affordable homes, adopted a new business plan focused on rental projects and selected cooperative apartment projects. As a result of the company's ongoing conversion to focus mainly on rental projects, SSM intends to reduce the number of employees working within sales and marketing. This is expected to contribute annual cost savings of 6.5 MSEK. Restructuring costs of 3.3 MSEK are expected to impact results for Q2 2020. In addition, SSM intends to introduce what are known as short-term work programme for parts of its staff

Avidly Plc has commenced negotiations on up to EUR 2.5 million debt financing

Avidly Plc has commenced negotiations on up to EUR 2.5 million debt financing Avidly Plc, inside information, 14 May 2020 at 9.00 am EEST Avidly Plc has commenced negotiations on maximum of 2.5 million euros debt financing to strengthen company’s liquidity and to support growth. The company aims to complete the financing negotiations by the end of June 2020. This release contains information which Avidly Plc makes public pursuant to the EU Market Abuse Regulation, article 17.   AVIDLY PLCBoard of Directors Additional information:Jesse Maula, CEO, Tel. +358 40 548 0248

A true pioneer in probiotic research is elected NutraChampion 2020

Bengt Jeppsson, one of the founders of Probi[®], elected NutraChampion winner Yesterday, Dr. Bengt Jeppsson was selected as the winner of the new NutraChampion category of Nutra Ingredients Awards. The jury’s selection was judged as “An important and lasting contribution to our industry and the wider causes of public health and nutrition, this award celebrates long-term and high-level personal achievements that have driven change within the science and business of our industry”. “It all started with a vision of saving lives” is the opening sentence often used by Professor Jeppsson

IMPACT COATINGS AGM 2020 – CEO PRESENTATION NOW AVAILABLE ON THE COMPANY WEBSITE

The Annual General Meeting (AGM) in Impact Coatings AB (publ) will be held today in Linköping. As announced in the convening notice, due to COVID-19 the AGM will be held in its simplest form, but with the opportunity for shareholders to exercise their rights.The CEO presentation to the AGM and other AGM documents are now available on the company's website, www.impactcoatings.com/arsstamma-2020/. The AGM bulletin will be sent after the close of the meeting. CEO Torbjörn Sandberg will also be presenting at Redeye Growth Day on June 2, which this year will be a web event. The presentation

There are no items matching the current filter
There are no more items matching the current filter
Back to top